Page 191 - 2022 Ranger Medic Handbook

ZOLPIDEM (AMBIEN) – CONTROLLED SUBSTANCE IV
Class: CNS agent – nonbenzodiazepine; anxiolytic, sedative-hypnotic
Action: Nonbenzodiazepine hypnotic that does not have muscle relaxant or anticonvulsant effects; preserves deep
sleep (stages 3 and 4) at hypnotic doses
Dose: 5–10mg PO qhs, limited to 7–10 days
Indications: For short-term treatment of insomnia
Contraindications: Pregnancy category consider alternative during pregnancy and caution advised while breastfeeding
Adverse/Side-effects: Headache on awakening, drowsiness or fatigue, lethargy, drugged feeling, depression, anxi-
ety, irritability, dizziness, double vision; doses > 10mg may be associated with anterograde amnesia or memory
impairment; dyspepsia, nausea, vomiting; myalgia
Interactions: CNS depressants, alcohol, and phenothiazines augment CNS depression; food significantly decreases
extent and rate of absorption, DO NOT give with or immediately after a meal
Mission Impact: Drowsiness

NEW DRUGS SECTION 4
Class:
Action:
Dose:
Indications:
Contraindications:
Adverse/Side-effects:
Interactions:
Mission Impact:
K9 Dosage:

Class:
Action:
Dose:
Indications:
Contraindications:
Adverse/Side-effects:
Interactions:
Mission Impact:
K9 Dosage:

2022 RANGER MEDIC HANDBOOK 177